Women in science: Where are we now?

As another International Day of Women and Girls in Science dawned, pharmaphorum’s Nicole Raleigh reflected on whether the modern pharma talent pipeline is as balanced and optimised as it co

Reinventing R&D in the age of AI - How intelligent technolog...

Life-changing interventions that have previously been pipedreams are now within reach for the biopharma industry, made possible through an increasingly sophisticated understanding of human

Cell therapies are the future of healthcare, why are we stru...

The future of healthcare is undeniably heading toward cell therapies, as they offer hope for diseases where, to date, we have not been able to provide treatments or cures.

JP Morgan Week 2025 – Ryan Spencer

Join CEO Ryan Spencer of Dynavax Technologies in a video interview discussing JP Morgan Week 2025

The irony of data in precision medicine: Igniting progress w...

As I regularly engage with pharma executives and biotech founders, a common theme inevitably arises: why is precision medicine taking so long to become a reality, and is technology to blame

Paediatric rare diseases: Children are not small adults